Nurix Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- GDPH413075D
- Pages: 20
- November 2018
- Total Views:1142
- Region : North America
- GlobalData
- Equity Research Report

Details
Summary
Nurix Inc (Nurix) formerly Kura Therapeutics Inc, is a drug development company that discovers and develops drugs which work by modulating the protein regulation machinery of the cell. The company developed a drug discovery platform based on understanding of the ubiquitin proteasome system (UPS) to restore normal cellular homeostasis. Nurix, through its proprietary Molecular Glue chemistry, identifies compounds that selectively re-engage the UPS to target harmful proteins. The company collaborated with Celgene for the discovery and development of next-generation therapies in oncology, immunology, and inflammation. Nurix is headquartered in San Francisco, California, the US.
Nurix Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Nurix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nurix Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nurix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nurix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Nurix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Nurix Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Nurix Raises USD17 Million in Financing Round 10
Nurix Raises USD25 Million in Series B Financing 11
Nurix Raises USD 2 Million In Venture Financing 12
Nurix Raises Additional USD 2.2 Million In Venture Financing 13
Nurix Secures USD3.1 Million in Venture Funding 14
Partnerships 15
Nurix Enters into Co-Development Agreement with Celgene 15
Nurix Enters into Partnership with Lunenfeld-Tanenbaum Research Institute 16
Nurix Inc-Key Competitors 17
Nurix Inc-Key Employees 18
Nurix Inc-Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20
List Of Figure
List of Figures
Nurix Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Nurix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Nurix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Nurix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Nurix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nurix Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Nurix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nurix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
List Of Table
List of Tables
Nurix Inc, Pharmaceuticals & Healthcare, Key Facts 2
Nurix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nurix Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nurix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nurix Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Nurix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Nurix Raises USD17 Million in Financing Round 10
Nurix Raises USD25 Million in Series B Financing 11
Nurix Raises USD 2 Million In Venture Financing 12
Nurix Raises Additional USD 2.2 Million In Venture Financing 13
Nurix Secures USD3.1 Million in Venture Funding 14
Nurix Enters into Co-Development Agreement with Celgene 15
Nurix Enters into Partnership with Lunenfeld-Tanenbaum Research Institute 16
Nurix Inc, Key Competitors 17
Nurix Inc, Key Employees 18
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
Nurix Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Company Profile
Company Profile Title
Summary
Nurix Inc (Nurix) formerly Kura Therapeutics Inc, is a drug development company that discovers and develops drugs which work by modulating the protein regulation machinery of the cell. The company developed a drug discovery platform based on understanding of the ubiquitin proteasome system (UPS) to restore normal cellular homeostasis. Nurix, through its proprietary Molecular Glue chemistry, identifies compounds that selectively re-engage the UPS to target harmful proteins. The company collaborated with Celgene for the discovery and development of next-generation therapies in oncology, immunology, and inflammation. Nurix is headquartered in San Francisco, California, the US.
Nurix Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Nurix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nurix Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nurix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nurix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Nurix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Nurix Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Nurix Raises USD17 Million in Financing Round 10
Nurix Raises USD25 Million in Series B Financing 11
Nurix Raises USD 2 Million In Venture Financing 12
Nurix Raises Additional USD 2.2 Million In Venture Financing 13
Nurix Secures USD3.1 Million in Venture Funding 14
Partnerships 15
Nurix Enters into Co-Development Agreement with Celgene 15
Nurix Enters into Partnership with Lunenfeld-Tanenbaum Research Institute 16
Nurix Inc-Key Competitors 17
Nurix Inc-Key Employees 18
Nurix Inc-Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20
List Of Figure
List of Figures
Nurix Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Nurix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Nurix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Nurix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Nurix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nurix Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Nurix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nurix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
List Of Table
List of Tables
Nurix Inc, Pharmaceuticals & Healthcare, Key Facts 2
Nurix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nurix Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nurix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nurix Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Nurix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Nurix Raises USD17 Million in Financing Round 10
Nurix Raises USD25 Million in Series B Financing 11
Nurix Raises USD 2 Million In Venture Financing 12
Nurix Raises Additional USD 2.2 Million In Venture Financing 13
Nurix Secures USD3.1 Million in Venture Funding 14
Nurix Enters into Co-Development Agreement with Celgene 15
Nurix Enters into Partnership with Lunenfeld-Tanenbaum Research Institute 16
Nurix Inc, Key Competitors 17
Nurix Inc, Key Employees 18
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
Nurix Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.